Caveolin-3 and in vitro culture of hepatitis c virus

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 7/02 (2006.01) A01K 67/027 (2006.01) C12Q 1/70 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2615558

Caveolin-3 has been identified as a cellular factor that associates with HCV protein El and E2, and is proposed as a cellular limiting factor. As an alternative possibility, caveolin-3 may act as a cellular receptor for HCV, acting alongside CD81. In either scenario, cells with increased expression of caveolin-3 will be better suited to the in vitro culture of HCV, and blocking the interaction between caveolin-3 and HCV proteins has therapeutic potential.

La cavéoline-3 a été identifiée comme étant un facteur cellulaire qui s'associe avec la protéine E1 et E2 du VHC et il a été proposé de l'utiliser en tant que facteur de limitation cellulaire. Selon une autre possibilité, la cavéoline-3 peut agir en tant que récepteur cellulaire pour le VHC, oeuvrant aux côtés de CD81. Dans les deux cas, l'expression accrue de la cavéoline-3 sera plus appropriée à la culture in vitro du VHC et le blocage de l'interaction entre la cavéoline-3 et les protéines VHC présente un potentiel thérapeutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Caveolin-3 and in vitro culture of hepatitis c virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Caveolin-3 and in vitro culture of hepatitis c virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Caveolin-3 and in vitro culture of hepatitis c virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1687929

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.